13-3　ⓔ文献

  1. Sumida T, Tsuboi H, et al: The role of M3 muscarinic acetylcholine receptor reactive T cells in Sjögren’s syndrome: a critical review. J Autoimmun, 2014; 51: 44–50.

  2. Fujibayashi T, Sugai S, et al: Revised Japanese criteria for Sjogren’s syndrome (1999): availability and validity. Mod Rheumatol, 2004; 14: 425–434.

  3. Seror R, Bootsma H, et al: Defining disease activity states and clinically meaningful improvement in primary Sjögren’s syndrome with EULAR primary Sjögren’s syndrome disease activity (ESSDAI) and patient–reported indexes (ESSPRI). Ann Rheum Dis, 2016; 75: 382–389.

  4. 住田孝之編：シェーグレン症候群診療ガイドライン2017年版，診断と治療社，2017．

  5. Sumida T, Azuma N, et al: Clinical practice guideline for Sjögren’s syndrome 2017. Mod Rheumatol, 2018; 28: 383–408.